National Toxicology Program

National Toxicology Program
https://ntp.niehs.nih.gov/go/17401

TDMS Study 99035-01 Pathology Tables

NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04
Route: GAVAGE                                                                                                     Time: 12:51:24

                                                            FINAL #1




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  556-52-5

       Lock Date:  09/24/01

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 2            1            2            1            4                        
    Natural Death                                                                1                         2                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                13           14           12           14            9                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Angiectasis, Focal                                                                      1 (7%)       2 (13%)                  
      Eosinophilic Focus                                                                                   1 (7%)                   
      Hematopoietic Cell Proliferation                 2 (13%)      3 (20%)      1 (7%)       1 (7%)       2 (13%)                  
      Infiltration Cellular, Lymphoid                               3 (20%)      1 (7%)       1 (7%)       1 (7%)                   
      Inflammation                                                  1 (7%)                                                          
      Inflammation, Chronic                           11 (73%)     10 (67%)      8 (53%)      8 (53%)      7 (47%)                  
      Mixed Cell Focus                                                           1 (7%)       1 (7%)                                
      Necrosis, Focal                                                            5 (33%)      2 (13%)      2 (13%)                  
      Midzonal, Fatty Change                           1 (7%)                                                                       
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Epithelium, Hyperplasia                                                                 1 (7%)       4 (27%)                  
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Metaplasia, Squamous                                                       1 (7%)                                             
      Mineralization                                   4 (27%)                                             2 (13%)                  
      Epithelium, Ectasia                                                        1 (7%)                                             
      Muscularis, Mineralization                                                                           2 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Myocardium, Mineralization                       1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia, Focal                                            2 (13%)                                1 (7%)                   
      Mineralization                                                                                       1 (7%)                   
      Vacuolization Cytoplasmic, Focal                 1 (7%)                                                                       
      Subcapsular, Hyperplasia                        15 (100%)    15 (100%)    10 (67%)     14 (93%)     15 (100%)                 
   Pituitary Gland                                    (15)         (15)         (15)         (15)         (15)                      
      Necrosis                                                                                             1 (7%)                   
      Pars Distalis, Hyperplasia, Focal                1 (7%)       1 (7%)       2 (13%)      1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                                                                         (1)                       
      Pigmentation, Melanin                                                                                1 (100%)                 
   Ovary                                              (15)         (15)         (15)         (15)         (15)                      
      Cyst                                             4 (27%)                                             2 (13%)                  
   Uterus                                             (15)         (15)         (15)         (15)         (15)                      
      Endometrium, Hyperplasia, Cystic                13 (87%)     14 (93%)     10 (67%)     14 (93%)      9 (60%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                                          1 (7%)                   
   Lymph Node                                         (13)         (15)         (15)         (13)         (14)                      
      Lumbar, Hyperplasia, Lymphoid                                 1 (7%)                                                          
      Mediastinal, Hyperplasia, Lymphoid               2 (15%)      1 (7%)                                                          
      Pancreatic, Hyperplasia, Lymphoid                                                                    1 (7%)                   
      Renal, Hyperplasia, Lymphoid                                                                         1 (7%)                   
   Lymph Node, Mandibular                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                            1 (7%)                                              1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                                                                   1 (7%)                                
      Inflammation, Suppurative                        1 (7%)                                                                       
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                 9 (60%)      5 (33%)     10 (67%)     10 (67%)     10 (67%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       2 (13%)                   1 (7%)       3 (20%)                  
      Hyperplasia, Lymphoid                                         1 (7%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                             1 (7%)                                
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Subcutaneous Tissue, Edema                                                                           1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Hyperostosis                                                                            1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (15)         (15)         (15)         (15)         (15)                      
      Cerebellum, Gliosis                                                                                  1 (7%)                   
      Cerebellum, Neuronopathy                                                                1 (7%)       3 (20%)                  
      Cerebrum, Cyst Epithelial Inclusion                                                                  1 (7%)                   
      Cerebrum, Hemorrhage                                                                    1 (7%)                                
      Medulla, Gliosis                                                                                     2 (13%)                  
      Medulla, Neuronopathy                                                                                3 (20%)                  
      Thalamus, Gliosis                                                                                    1 (7%)                   
      Thalamus, Neuronopathy                                                                               3 (20%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation                                     8 (53%)      8 (53%)      7 (47%)      5 (33%)      3 (20%)                  
      Inflammation, Granulomatous                      1 (7%)                                                                       
      Alveolar Epithelium, Hyperplasia, Focal          1 (7%)       2 (13%)      1 (7%)                    1 (7%)                   
      Arteriole, Inflammation, Acute                   1 (7%)                                                                       
      Bronchus, Foreign Body                           1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Lymphoid                               1 (7%)                                                          
      Metaplasia, Osseous                                                                                  1 (7%)                   
      Nephropathy                                     12 (80%)     12 (80%)     10 (67%)     14 (93%)      9 (60%)                  
      Renal Tubule, Accumulation, Hyaline Droplet                                2 (13%)      1 (7%)       3 (20%)                  
   Urinary Bladder                                    (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                            1 (7%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Natural Death                                      2            1            1            1            3                        
    Moribund Sacrifice                                                           1                         4                        
    Dosing Accident                                                                                        1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                13           14           13           14            7                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                                                    (1)                                                 
      Inflammation, Acute                                                        1 (100%)                                           
   Intestine Small, Jejunum                           (15)         (15)         (15)         (15)         (15)                      
      Peyer's Patch, Hyperplasia, Atypical                          1 (7%)                                                          
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (7%)                                                          
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Angiectasis, Focal                                                                                   1 (7%)                   
      Basophilic Focus                                              1 (7%)                                                          
      Degeneration, Cystic                             1 (7%)                                                                       
      Eosinophilic Focus                                                                                   1 (7%)                   
      Fatty Change, Focal                                                                     1 (7%)                                
      Hematopoietic Cell Proliferation                              1 (7%)                    2 (13%)      1 (7%)                   
      Hemorrhage                                                                 1 (7%)                                             
      Infiltration Cellular, Lymphoid                  1 (7%)       2 (13%)                   2 (13%)      1 (7%)                   
      Inflammation, Chronic                            6 (40%)      9 (60%)      8 (53%)      9 (60%)      2 (13%)                  
      Mixed Cell Focus                                                                        1 (7%)                                
      Necrosis, Focal                                  1 (7%)       2 (13%)      2 (13%)                   5 (33%)                  
   Mesentery                                                       (1)                                                              
      Fat, Necrosis                                                 1 (100%)                                                        
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Ulcer                                                         1 (7%)                                 3 (20%)                  
      Epithelium, Hyperplasia                                       1 (7%)       1 (7%)                    6 (40%)                  
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                      1 (7%)                                             
      Mineralization                                  10 (67%)                                5 (33%)      1 (7%)                   
      Ulcer                                                                                                1 (7%)                   
      Epithelium, Hyperplasia                                       1 (7%)                                                          
      Glands, Ectasia                                                            1 (7%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Muscularis, Mineralization                                                              1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Mast Cell                                                                     1 (7%)                   
      Epicardium, Inflammation, Chronic                1 (7%)                                                                       
      Myocardium, Degeneration                         2 (13%)                                2 (13%)                               
      Myocardium, Mineralization                                                 2 (13%)      1 (7%)       5 (33%)                  
      Myocardium, Necrosis                                                                                 2 (13%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (15)         (14)         (15)                      
      Hyperplasia, Focal                               1 (7%)                                 1 (7%)                                
      Subcapsular, Hyperplasia                         1 (7%)       2 (13%)      2 (13%)      3 (21%)      1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (15)         (15)         (15)         (15)         (15)                      
      Fibrosis                                                      1 (7%)                                                          
   Preputial Gland                                                              (1)                                                 
      Inflammation, Suppurative                                                  1 (100%)                                           
   Testes                                             (15)         (15)         (15)         (15)         (15)                      
      Germinal Epithelium, Degeneration                             1 (7%)                                 1 (7%)                   
      Germinal Epithelium, Mineralization                           1 (7%)                                                          
      Germinal Epithelium, Necrosis                    1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (14)         (14)         (15)         (13)         (13)                      
      Mediastinal, Hyperplasia, Lymphoid                            1 (7%)                                                          
   Lymph Node, Mandibular                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Lymphoid                                         2 (13%)                   1 (7%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Inflammation, Suppurative                                                  1 (7%)                                             
      Necrosis                                                                                             1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (14)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                                                          
      Hyperplasia, Lymphoid                                         2 (13%)                   1 (7%)       1 (7%)                   
      Inflammation, Suppurative                                     1 (7%)                                 1 (7%)                   
      Necrosis                                                                                             1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Angiectasis                                                                                          1 (7%)                   
      Atrophy                                                                                 1 (7%)       2 (13%)                  
      Hematopoietic Cell Proliferation                 4 (27%)      7 (47%)      7 (47%)      5 (33%)      5 (33%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                          2 (13%)                   1 (7%)                    4 (27%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Ulcer                                                                                                1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Hyperostosis                                     1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                   1 (7%)                                                                       
      Cerebellum, Gliosis                                                                                  2 (13%)                  
      Cerebellum, Hemorrhage, Focal                                                                        1 (7%)                   
      Cerebellum, Neuronopathy                                                                             3 (20%)                  
      Cerebrum, Hemorrhage                                                                                 1 (7%)                   
      Cerebrum, Necrosis, Focal                                                                            2 (13%)                  
      Hippocampus, Hemorrhage                                                                              1 (7%)                   
      Hippocampus, Necrosis                                                      1 (7%)                    1 (7%)                   
      Medulla, Gliosis                                                                                     2 (13%)                  
      Medulla, Neuronopathy                                                                                3 (20%)                  
      Thalamus, Gliosis                                                                                    2 (13%)                  
      Thalamus, Neuronopathy                                                                               5 (33%)                  
   Spinal Cord                                                                               (1)                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 99035-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (GLYCIDOL)                         Date: 03/31/04    
Route: GAVAGE                                                                                                     Time: 12:51:24    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Axon, Degeneration                                                                      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Hemorrhage                                                                                           1 (7%)                   
      Inflammation                                     3 (20%)      7 (47%)      5 (33%)      4 (27%)      2 (13%)                  
      Inflammation, Granulomatous                                                1 (7%)                                             
      Alveolar Epithelium, Hyperplasia, Focal                       2 (13%)                   2 (13%)      2 (13%)                  
      Bronchiole, Hyperplasia                                                    1 (7%)                                             
      Vein, Thrombosis                                                           1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Hydronephrosis                                                                                       1 (7%)                   
      Infarct                                                                                              1 (7%)                   
      Nephropathy                                      4 (27%)      5 (33%)      5 (33%)      4 (27%)      4 (27%)                  
      Renal Tubule, Accumulation, Hyaline Droplet                                1 (7%)                    1 (7%)                   
   Urinary Bladder                                    (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                                                                                1 (7%)                   
      Transitional Epithelium, Hyperplasia             1 (7%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           
NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.